Circulating IL-1β has also been found to be elevated in a patient with RDEB, and treatment with an anti-IL-1β monoclonal antibody significantly improved wound healing and reduced new blister formation; however, its efficacy waned over time (27). The gene discussed is IL1B; the disease is recessive dystrophic epidermolysis bullosa.